<code id='2790724682'></code><style id='2790724682'></style>
    • <acronym id='2790724682'></acronym>
      <center id='2790724682'><center id='2790724682'><tfoot id='2790724682'></tfoot></center><abbr id='2790724682'><dir id='2790724682'><tfoot id='2790724682'></tfoot><noframes id='2790724682'>

    • <optgroup id='2790724682'><strike id='2790724682'><sup id='2790724682'></sup></strike><code id='2790724682'></code></optgroup>
        1. <b id='2790724682'><label id='2790724682'><select id='2790724682'><dt id='2790724682'><span id='2790724682'></span></dt></select></label></b><u id='2790724682'></u>
          <i id='2790724682'><strike id='2790724682'><tt id='2790724682'><pre id='2790724682'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:37148
          Golden brain and DNA spiral illustration. -- biotech coverage from STAT
          Adobe

          The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions. 

          Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year. 

          advertisement

          Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Scrutiny of post
          Scrutiny of post

          AtableladenwithPPEandmedicalsuppliessuchassplitsponges,disposablebloodpressurecuffs,andgloves.DavidJ

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Fentanyl is making it harder to start addiction treatment

          PacketsofbuprenorphineEliseAmendola/APDoctorsarereportingatroublingtrendwhenitcomestofentanyl.Thepow